Arrowhead Research | ARWR - Market Capitalization



Arrowhead Research reported $3.53B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Agios Pharmaceuticals USD 1.93B 234M Jun/2025
Alnylam Pharmaceuticals USD 42.52B 7.39B Jun/2025
Arrowhead Research USD 2.18B 433M Jun/2025
Incyte USD 13.18B 1.46B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
Ligand Pharmaceuticals USD 2.19B 168M Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Moderna USD 10.67B 290M Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Sarepta Therapeutics USD 1.68B 4.51B Jun/2025
TG Therapeutics USD 5.71B 526M Jun/2025
Ultragenyx Pharmaceutical USD 3.44B 38M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025
Xencor USD 559M 191M Jun/2025